These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17294451)

  • 1. Circulating KL-6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma.
    Inata J; Hattori N; Yokoyama A; Ohshimo S; Doi M; Ishikawa N; Hamada H; Kohno N
    Int J Cancer; 2007 Jun; 120(12):2643-9. PubMed ID: 17294451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucins carrying selectin ligands as predictive biomarkers of disseminated intravascular coagulation complication in ARDS.
    Nakashima T; Yokoyama A; Inata J; Ishikawa N; Haruta Y; Hattori N; Kohno N
    Chest; 2011 Feb; 139(2):296-304. PubMed ID: 20671055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
    Satoh H; Ishikawa H; Kamma H; Yamashita YT; Takahashi H; Ohtsuka M; Hasegawa S
    Clin Cancer Res; 1997 Apr; 3(4):495-9. PubMed ID: 9815711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Ishikawa N; Hattori N; Yokoyama A; Tanaka S; Nishino R; Yoshioka K; Ohshimo S; Fujitaka K; Ohnishi H; Hamada H; Arihiro K; Kohno N
    Int J Cancer; 2008 Jun; 122(11):2612-20. PubMed ID: 18324627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
    Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
    Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma.
    Hamada H; Kohno N; Hiwada K
    Jpn J Cancer Res; 1994 Feb; 85(2):211-9. PubMed ID: 8144402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer.
    Hirasawa Y; Kohno N; Yokoyama A; Kondo K; Hiwada K; Miyake M
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):589-94. PubMed ID: 10673204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9.
    Kohno N; Inoue Y; Hamada H; Fujioka S; Fujino S; Yokoyama A; Hiwada K; Ueda N; Akiyama M
    Int J Cancer Suppl; 1994; 8():81-3. PubMed ID: 8194900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.
    Yokoyama A; Kondo K; Nakajima M; Matsushima T; Takahashi T; Nishimura M; Bando M; Sugiyama Y; Totani Y; Ishizaki T; Ichiyasu H; Suga M; Hamada H; Kohno N
    Respirology; 2006 Mar; 11(2):164-8. PubMed ID: 16548901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
    Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
    Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel monoclonal antibody, H9, directed against the core protein of MUC1 mucin.
    Hamada H; Kohno N; Yokoyama A; Kondo K; Yang SZ; Hiwada K; Watanabe K; Miyake M
    Oncol Rep; 2000; 7(2):225-32. PubMed ID: 10671662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
    Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
    BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.
    Laack E; Nikbakht H; Peters A; Kugler C; Jasiewicz Y; Edler L; Brümmer J; Schumacher U; Hossfeld DK
    J Clin Oncol; 2002 Nov; 20(21):4279-84. PubMed ID: 12409325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
    Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
    Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
    Zhang K; Baeckström D; Brevinge H; Hansson GC
    J Cell Biochem; 1996 Mar; 60(4):538-49. PubMed ID: 8707893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.
    Satoh H; Kurishima K; Ishikawa H; Ohtsuka M
    J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel classification of MUC1 expression is correlated with tumor differentiation and postoperative prognosis in non-small cell lung cancer.
    Nagai S; Takenaka K; Sonobe M; Ogawa E; Wada H; Tanaka F
    J Thorac Oncol; 2006 Jan; 1(1):46-51. PubMed ID: 17409826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.